The CXCL12/CXCR4 axis can modulate the immune microenvironment of tumors by attracting regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), which suppress anti-tumor immune responses. The gene discussed is CXCR4; the disease is neoplasm.